Danaher Corporation $DHR Stock Position Reduced by Wealthfront Advisers LLC

Wealthfront Advisers LLC decreased its position in Danaher Corporation (NYSE:DHR) by 17.6% in the 1st quarter, Holdings Channel.com reports. The fund owned 48,908 shares of the conglomerate’s stock after selling 10,455 shares during the period. Wealthfront Advisers LLC’s holdings in Danaher were worth $9,273,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in the company. JPL Wealth Management LLC bought a new position in Danaher during the third quarter worth $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher in the fourth quarter worth $26,000. WFA of San Diego LLC bought a new stake in Danaher during the second quarter valued at $26,000. Hilton Head Capital Partners LLC bought a new stake in Danaher during the fourth quarter valued at $27,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Barclays reduced their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Argus lowered their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. JPMorgan Chase & Co. dropped their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Guggenheim cut their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, The Goldman Sachs Group decreased their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $231.64.

Danaher Stock Performance

DHR stock opened at $203.65 on Friday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market capitalization of $144.14 billion, a price-to-earnings ratio of 39.39, a PEG ratio of 2.53 and a beta of 0.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock’s fifty day moving average is $183.27 and its two-hundred day moving average is $198.47.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the firm earned $1.88 earnings per share. The company’s quarterly revenue was up 3.7% on a year-over-year basis. On average, research analysts predict that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s dividend payout ratio is 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.